53
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL PAPERS

Establishment of immortalized mesenchymal stromal cells with red fluorescence protein expression for in vivo transplantation and tracing in the rat model with traumatic brain injury

, , , , &
Pages 455-465 | Received 07 Jul 2009, Accepted 14 Dec 2009, Published online: 15 Mar 2010

References

  • Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, . Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–7.
  • Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997;276:71–4.
  • Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976;4:267–74.
  • Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000; 109:235–42.
  • Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, . Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7:211–28.
  • Williams JT, Southerland SS, Souza J, Calcutt AF, Cartledge RG. Cells isolated from adult human skeletal muscle capable of differentiating into multiple mesodermal phenotypes. Am Surg. 1999;65:22–6.
  • In't Anker PS, Scherjon SA, Kleijburg-van der Keur C, Noort WA, Claas FH, Willemze R, . Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood. 2003;102:1548–9.
  • Campisi J. The biology of replicative senescence. Eur J Cancer. 1997;33:703–9.
  • Banfi A, Muraglia A, Dozin B, Mastrogiacomo M, Cancedda R, Quarto R. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp Hematol. 2000;28:707–15.
  • Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem. 1997;64: 278–94.
  • Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature. 1990;345: 458–60.
  • Greider CW. Telomeres, telomerase and senescence. Bioassays. 1990;12:363–9.
  • Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, . Extension of life-span by introduction of telomerase into normal human cells. Science. 1998;279: 349–52.
  • Morales CP, Holt SE, Ouellette M, Kaur KJ, Yan Y, Wilson KS, . Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat Genet. 1999; 21:115–8.
  • Terai M, Uyama T, Sugiki T, Li XK, Umezawa A, Kiyono T. Immortalization of human fetal cells: the life span of umbilical cord blood-derived cells can be prolonged without manipulating p16INK4a/RB braking pathway. Mol Biol Cell. 2005;16:1491–9.
  • Simonsen JL, Rosada C, Serakinci N, Justesen J, Stenderup K, Rattan SI, . Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol. 2002;20:592–6.
  • Abdallah BM, Haack-Sorensen M, Burns JS, Elsnab B, Jakob F, Hokland P, . Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation. Biochem Biophys Res Commun. 2005;326:527–38.
  • Boker W, Yin Z, Drosse I, Haasters F, Rossmann O, Wierer M, . Introducing a single-cell-derived human mesenchymal stem cell line expressing hTERT after lentiviral gene transfer. J Cell Mol Med. 2008;12:1347–59.
  • Huang G, Zheng Q, Sun J, Guo C, Yang J, Chen R, . Stabilization of cellular properties and differentiation mutilpotential of human mesenchymal stem cells transduced with hTERT gene in a long-term culture. J Cell Biochem. 2008; 103:1256–69.
  • Bleiziffer O, Eriksson E, Yao F, Horch RE, Kneser U. Gene transfer strategies in tissue engineering. J Cell Mol Med. 2007;11:206–23.
  • Burns JS, Abdallah BM, Guldberg P, Rygaard J, Schroder HD, Kassem M. Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells. Cancer Res. 2005; 65:3126–35.
  • Serakinci N, Guldberg P, Burns JS, Abdallah B, Schrodder H, Jensen T, . Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene. 2004;23: 5095–8.
  • Gao X, Kim KS, Liu D. Nonviral gene delivery: what we know and what is next. The American Association of Pharmaceutical Scientists Journal (AAPS J). http://www.aapsj.org. 2007;9:E92–104.
  • Thomas M, Klibanov AM. Non-viral gene therapy: polycation-mediated DNA delivery. Appl Microbiol Biotechnol. 2003;62:27–34.
  • Chang YJ, Shih DT, Tseng CP, Hsieh TB, Lee DC, Hwang SM. Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood. Stem Cells. 2006;24:679–85.
  • Phinney DG, Prockop DJ. Concise review. Mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair – current views. Stem Cells. 2007;25:2896–902.
  • Blesch A. Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer. Methods. 2004;33:164–72.
  • Check E. A tragic setback. Nature. 2002;420:116–8.
  • Marshall E. Gene therapy death prompts review of adenovirus vector. Science. 1999;286:2244–5.
  • Bokhoven M, Stephen SL, Knight S, Gevers EF, Robinson IC, Takeuchi Y, . Insertional gene activation by lentiviral and gammaretroviral vectors. J Virol. 2009;83:283–94.
  • Qu C, Mahmood A, Lu D, Goussev A, Xiong Y, Chopp M. Treatment of traumatic brain injury in mice with marrow stromal cells. Brain Res. 2008;1208:234–9.
  • Sobajima S, Vadala G, Shimer A, Kim JS, Gilbertson LG, Kang JD. Feasibility of a stem cell therapy for intervertebral disc degeneration. Spine J. 2008;8:888–96.
  • Hill JM, Dick AJ, Raman VK, Thompson RB, Yu ZX, Hinds KA, . Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation. 2003;108: 1009–14.
  • Bhakta S, Hong P, Koc O. The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation. Cardiovasc Revasc Med. 2006;7:19–24.
  • Finnie JW, Blumbergs PC. Traumatic brain injury. Vet Pathol. 2002;39:679–89.
  • Blumbergs PC, Jones NR, North JB. Diffuse axonal injury in head trauma. J Neurol Neurosurg Psychiatry. 1989;52: 838–41.
  • Aluigi M, Fogli M, Curti A, Isidori A, Gruppioni E, Chiodoni C, . Nucleofection is an efficient nonviral transfection technique for human bone marrow-derived mesenchymal stem cells. Stem Cells. 2006;24:454–61.
  • Greider CW. Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci USA. 1998;95:90–2.
  • Huang Q, Chen M, Liang S, Acha V, Liu D, Yuan F, . Improving cell therapy: experiments using transplanted telomerase-immortalized cells in immunodeficient mice. Mech Ageing Dev. 2007;128:25–30.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.